BFC Planning, Inc.’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
BFC Planning, Inc.'s VRTX Position: Q2 2026 in Review
BFC Planning, Inc. increased its Vertex Pharmaceuticals (VRTX) stake by 3.1% in Q2 2026, buying an estimated $25.7K and bringing the position to 1,956 shares worth $972K. The position accounts for 0.04% of the portfolio, ranked #405.
BFC Planning, Inc. first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 1,770 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- BFC Planning, Inc. held 1,956 shares of Vertex Pharmaceuticals worth $972K as of Q2 2026.
- BFC Planning, Inc. bought 58 Vertex Pharmaceuticals shares in Q2 2026, an estimated $25.7K.
- Vertex Pharmaceuticals made up 0.04% of BFC Planning, Inc.'s portfolio in Q2 2026, its #405 holding.
- BFC Planning, Inc. first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- 1,770 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.